Passive Immunization with Human Neutralizing Monoclonal Antibodies Against HIV-1 in Macaque Models: Experimental Approaches
Reference7 articles.
1. Flynn, N.M., Forthal, D.N., Harro, C.D., Judson, F.N., Mayer, K.H., and Para, M.F. (2005) Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. J. Infect. Dis.
191, 654–665. 2. Pitisuttithum, P., Gilbert, P., Gurwith, M., Heyward, W., Martin M., van Griensven F., et al. (2006) Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. J. Infect. Dis.
194, 1661–1671. 3. Mc Cann, C.M., Song, R.J., and Ruprecht, R.M. (2005) Antibodies: can they protect against HIV infection? Curr. Drug Targets Infect. Disord.
5, 95–111. 4. Kramer, V.G., Siddappa, N.B., and Ruprecht, R.M. (2007) Passive immunization as tool to identify protective HIV-1 Env epitopes. Curr. HIV Res.
5, 642–655. 5. Ferrantelli, F., Rasmussen, R.A., Buckley, K.A., Li, P.L., Wang, T., Montefiori, D.C., et al. (2004) Complete protection of neonatal rhesus macaques against oral exposure to pathogenic simian-human immunodeficiency virus by human anti-HIV monoclonal antibodies. J. Infect. Dis.
189, 2167–2173.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|